Trial · NCT07891091
SUTURE TYPE AND RECURRENCE RISK AFTER INCISIONAL HERNIA REPAIR
NCT07891091, Not applicable, Not yet recruiting, Ersta Diakoni
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. SUTURE TYPE AND RECURRENCE RISK AFTER INCISIONAL HERNIA REPAIR. Trials, record NCT07891091. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891091
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- SUTURE TYPE AND RECURRENCE RISK AFTER INCISIONAL HERNIA REPAIR
- NCT number
- NCT07891091
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 980 participants, estimated
- Lead sponsor
- Ersta Diakoni
- Conditions
- Ventral Incisional Hernia
- Interventions
- Suturing of hernia defect with non-absorbable suture, Suturing of hernia defect with slowly absorbable suture
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Primary Outcome Measure - Number of patients with a CT-verified recurrence up to 2 years after surgery | From day of surgery up to 24 months postoperatively | The primary objective is to evaluate whether the choice of suture material for fascial defect closure in minimally invasive (laparoscopic or robot-assisted) retromuscular incisional hernia repair affects the risk of recurrence, defined as CT-verified recurrence 2 years after surgery. The trial uses a hierarchical framework: first, superiority of non-absorbable versus slowly absorbable suture is tested for 2-year recurrence. If superiority is not demonstrated, non-inferiority of slowly absorbable versus non-absorbable suture is tested within a pre-specified clinically relevant margin. |
| Secondary | Perioperative outcomes | Recorded at day of surgery | Perioperative outcomes, including operating time, needof conversion to open surgery and any occurences of intraoperative complications (i.e. major bleeding, bowel injury) |
| Secondary | Length of hospital stay | From admission day (usually day of surgery) up to 30 days postoperatively | Nunmber of days from admission to discharge from hospital, alternatively proportion of patients not discharged after 30 days postoperatively |
| Secondary | Short-term postoperative complications | From day of surgery to 30 days postoperatively | Short-term postoperative complications, including surgical site occurrence/infection and other hernia-related complications (SSO/SSI, seroma, hematoma), classified using Clavien-Dindo, within 30 days. |
| Secondary | Clinical long-term outcomes | From day of surgery up to 36 months postoperatively | Reoperations (any indication), mesh-related complications, bulging and other hernia-related long-term complications from day of surgery up to 3 years. |
| Secondary | Patient-reported long-term outcomes | From baseline to 36 months postoperatively | Patient-reported long-term outcomes on pain, function and health-related quality of life measured using validated instruments (VHPQ and/or NRS for pain; Hernia-Q for quality of life) at baseline and at 30 days, 1 year, 2 years and 3 years. |
| Secondary | Health economics | From time of surgery up to 36 months postoperatively | Resource use and exploratory health-economic measures based on healthcare contacts, follow-up visits and reoperations during follow-up |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07891091
GET https://conductscience.org/api/trials/v1/NCT07891091/registered